top of page

See if You Qualify

Eligibility

  • Documented diagnosis of Prader-Willi syndrome (PWS)

  • Age 7 years old or older

  • Primary caregiver that can commit to the trial requirements for 16 weeks

Study Details

  • Eligible participants will either receive investigational drug or placebo (no active investigational drug ingredients)

  • Investigational drug will be taken orally twice daily for 12 weeks

  • Approximately 4 in-person visits and 3 telehealth visits are required

  • Travel and accommodation (if required) for the participant and a primary caregiver will be covered

  • No fasting required

  • All participants who complete the HERO study will have the option to participate in a follow-up study where everyone will receive the investigational drug

Study Locations

  • Find the clinical centre nearest you

bottom of page